Management of SVT with Hypotension
Proceed immediately to synchronized cardioversion at 50-100J for any patient with SVT and hypotension—this is a Class I recommendation with essentially 100% success rate and should not be delayed for vagal maneuvers or pharmacologic therapy. 1, 2
Immediate Hemodynamic Assessment
Hypotension in the setting of SVT defines hemodynamic instability and mandates emergent electrical cardioversion. 1, 3, 4
Other signs of hemodynamic instability that warrant the same immediate approach include: 1, 4
- Acutely altered mental status
- Signs of shock
- Chest pain suggesting ischemia
- Acute heart failure symptoms
Acute Management Algorithm
For Hemodynamically Unstable Patients (Hypotension Present)
Step 1: Synchronized Cardioversion
- Perform synchronized cardioversion immediately without attempting vagal maneuvers or adenosine first. 1, 2, 4
- Initial energy should be 50-100J for SVT. 4
- Success rate is essentially 100% in restoring sinus rhythm. 1, 4
- Adequate sedation or anesthesia should be provided if the clinical situation permits brief delay. 1
Critical Pitfall to Avoid:
- Do not delay cardioversion to attempt vagal maneuvers or administer adenosine in hypotensive patients—sinus rhythm must be promptly restored. 1
- Do not administer calcium channel blockers (verapamil, diltiazem) or beta-blockers to hypotensive patients, as these can worsen hemodynamic compromise. 1
Special Consideration: If Adenosine is Considered Before Cardioversion
The 2015 ACC/AHA/HRS guidelines state that adenosine may be considered first if the tachycardia is regular and has a narrow QRS complex, even in the presence of hypotension. 1
However, this represents a nuanced clinical decision:
- Adenosine 6 mg rapid IV bolus through a proximal vein with immediate saline flush has a 90-95% success rate for AVNRT/AVRT. 3, 5
- This approach should only be attempted if: 1, 3
- The rhythm is clearly regular and narrow-complex
- IV access is already established
- Cardioversion equipment is immediately available
- The patient is not in frank shock
In practice, synchronized cardioversion remains the safest and most definitive approach for hypotensive SVT and should not be delayed. 1, 2
Post-Conversion Management
After successful cardioversion: 4
- Monitor for atrial or ventricular premature complexes that may reinitiate tachycardia
- Consider antiarrhythmic medication to prevent acute reinitiation
- Arrange cardiology follow-up for consideration of catheter ablation (94.3-98.5% single-procedure success rate) to prevent recurrence 4, 5
What NOT to Do in Hypotensive SVT
Contraindicated interventions: 1, 6
- Do not give IV verapamil or diltiazem—these agents should only be used in hemodynamically stable patients and can cause further hypotension and acute worsening of heart failure 1, 6
- Do not give IV beta-blockers—these are only reasonable for hemodynamically stable patients 1, 2
- Do not delay definitive therapy with prolonged attempts at vagal maneuvers 1
Additional consideration: If serum potassium is <3.3 mEq/L, correct this urgently as severe hypokalemia can contribute to hemodynamic instability and increase risk of life-threatening arrhythmias, though cardioversion should not be delayed if the patient is unstable. 3